** Shares of Argenica Therapeutics rise as much as 12% to A$0.745, logs biggest intraday pct gain since Aug. 14
** Drug developer reports positive results in safety studies required for Investigational New Drug application $(IND.AU)$ by the U.S. FDA for its ARG-007 drug, aimed at treating acute ischemic stroke, a form of brain stroke
** IND application is a request for authorisation to administer experimental drugs to humans
** Co says opening an IND will enable it to conduct later stage clinical trials in the U.S.
** Stock up 36.3% YTD, as at 0551 GMT
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。